Demonstration of persistence of Salmonella typhimurium in an AIDS patient by molecular methods

A E Fica1, H W Horowitz, H Lior

  • 1Department of Microbiology and Immunology, New York Medical College, Valhalla.

Insights

Salmonella typhimurium persisted in an AIDS patient for 7 months, resisting quinolone therapy. Genetic analysis confirmed the same bacterial strain remained throughout the observation period.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • AIDS Research

Background:

  • Antimicrobial resistance is a growing global health concern, particularly in immunocompromised individuals.
  • Salmonella typhimurium infections can cause severe illness, especially in patients with Acquired Immunodeficiency Syndrome (AIDS).
  • Quinolone antibiotics are commonly used to treat Salmonella infections.

Observation:

  • This study observed a single AIDS patient over a 7-month period.
  • The patient received prolonged quinolone therapy for a Salmonella typhimurium infection.
  • Sequential isolates of the bacterium were collected and analyzed.

Findings:

  • Microbiological persistence of the identical Salmonella typhimurium strain was documented throughout the 7-month observation.
  • The persistent strain exhibited conserved characteristics including phage type, antibiotic resistance patterns, and genetic markers (RFLP, ribotypes, IS200 types).
  • Despite prolonged quinolone treatment, the same strain of S. typhimurium remained in the patient.

Implications:

  • This case highlights the potential for prolonged microbiological persistence of Salmonella typhimurium in AIDS patients, even with extended quinolone therapy.
  • Understanding mechanisms of bacterial persistence is crucial for developing effective treatment strategies in immunocompromised populations.
  • Further research is needed to explore factors contributing to treatment failure and persistent infections in AIDS patients.

Related Concept Videos